| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.0953-816X.2001.01583.X |
| P698 | PubMed publication ID | 11422448 |
| P2093 | author name string | Blier P | |
| Szabo ST | |||
| P2860 | cites work | Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers | Q34502908 |
| Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain | Q35041707 | ||
| Presynaptic Alpha-Receptor Subsensitivity After Long-Term Antidepressant Treatment | Q40174097 | ||
| Feedback Inhibition of Brain Noradrenaline Neurons by Tricyclic Antidepressants: α-Receptor Mediation | Q40186365 | ||
| Presynaptic noradrenergic regulation during depression and antidepressant drug treatment | Q40295606 | ||
| Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors | Q40691612 | ||
| Current advances and trends in the treatment of depression | Q41028584 | ||
| Locus coeruleus-to-dorsal raphe input examined by electrophysiological and morphological methods | Q41055446 | ||
| Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats | Q41740558 | ||
| Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system | Q41826769 | ||
| Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor | Q43503047 | ||
| Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons | Q44754130 | ||
| Chronic electroconvulsive shock and desimipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes | Q48098351 | ||
| Dependence of serotonin release in the locus coeruleus on dorsal raphe neuronal activity | Q48106015 | ||
| A 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons | Q48298237 | ||
| In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus | Q48328090 | ||
| Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons | Q48374891 | ||
| Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors | Q48433394 | ||
| Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine | Q48450328 | ||
| Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission | Q48479039 | ||
| Idazoxan (RX 781094) selectively antagonizes α2-adrenoceptors on rat central neurons | Q48613001 | ||
| Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices | Q48704361 | ||
| Electrophysiological demonstration of both α2-agonist and antagonist properties of RX 781094 | Q48776143 | ||
| Projections of the nucleus locus coeruleus in the albino rat | Q48975329 | ||
| Functional evidence for subsensitivity of noradrenergic α2 receptors after chronic desipramine treatment | Q49144579 | ||
| Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists | Q58414773 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serotonin | Q167934 |
| norepinephrine | Q186242 | ||
| P304 | page(s) | 2077-2087 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | European Journal of Neuroscience | Q5412733 |
| P1476 | title | Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons | |
| P478 | volume | 13 |
| Q46121282 | 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats |
| Q46621322 | A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test |
| Q37236791 | Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons |
| Q34234907 | Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis |
| Q37486288 | Atomoxetine attenuates dextroamphetamine effects in humans |
| Q34020868 | Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortex |
| Q59314011 | Blockade of autoreceptor-mediated inhibition of norepinephrine release by atipamezole is maintained after chronic reuptake inhibition |
| Q43165318 | Characterization of the electrophysiological properties of triple reuptake inhibitors on monoaminergic neurons |
| Q42761675 | Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortex |
| Q42473400 | Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus |
| Q46923593 | Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex. |
| Q42503551 | Chronic treatment with desipramine improves cognitive performance of rats in an attentional set-shifting test |
| Q50905174 | Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. |
| Q47644422 | Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation |
| Q43235418 | Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of monoaminergic neurons |
| Q43787070 | Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity |
| Q46417443 | Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons |
| Q44102461 | Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. |
| Q43813687 | Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons |
| Q46800578 | Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions |
| Q34660430 | Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus. |
| Q35765941 | Human locus coeruleus neurons express the GABA(A) receptor gamma2 subunit gene and produce benzodiazepine binding |
| Q42470825 | Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease. |
| Q55421497 | Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs). |
| Q43516983 | Monoaminergic modulation of behavioural and electrophysiological indices of error processing. |
| Q44644323 | Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging. |
| Q35094650 | New approaches to developing antidepressants by enhancing monoaminergic neurotransmission |
| Q42912275 | Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD. |
| Q24656833 | Norepinephrine and stimulant addiction |
| Q27687469 | Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits |
| Q38112732 | Rational site-directed pharmacotherapy for major depressive disorder |
| Q37734565 | Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder |
| Q44461612 | Selective decrease in serotonin synthesis rate in rat brainstem raphe nuclei following chronic administration of low doses of amitriptyline: an effect compatible with an anti-migraine effect |
| Q43257881 | Serotonergic mechanisms on breathing modulation in the rat locus coeruleus |
| Q44543852 | Spinal and supraspinal functions of noradrenaline in the frog embryo: consequences for motor behaviour |
| Q36018497 | Structural and functional models of depression: from sub-types to substrates. |
| Q39122800 | The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder |
| Q44438234 | The efficacy of reboxetine in preventing and reverting a condition of escape deficit in rats. |
| Q34088962 | The locus coeruleus and central chemosensitivity |
| Q28185617 | The pharmacology of putative early-onset antidepressant strategies |
| Q34280197 | The promises and pitfalls of reboxetine |
| Q30497737 | The role of the noradrenergic system in the exploration-exploitation trade-off: a psychopharmacological study |
| Q33976127 | The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. |
Search more.